AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 7755164
Drug: aminoglycoside plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: aminoglycoside plus antianaerobic therapy
Trial: 3031574
Drug: RIT 4237
RxNorm normalized name: measles virus vaccine live, attenuated Schwarz strain / mumps virus vaccine live, RIT-4385 strain / rubella virus vaccine live (Wistar RA 27-3 strain) Injection [Priorix]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RIT 4237 bovine rotavirus vaccine
Trial: 29187694
Drug: 4 mg/day
RxNorm normalized name: Neupro 4 MG/Day 24 HR Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg/day pitavastatin
Trial: 7987882
Drug: 10 mg/day
RxNorm normalized name: Adlarity 10 MG/Day Weekly Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg/day pravastatin
Trial: 27264413
Drug: 30 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg/day fluvastatin
Trial: 19442931
Drug: Indomethacin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (100 mg, oral, 90 min)
Trial: 14693528
Drug: GW433908 1,395
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GW433908 1,395 mg BID
Trial: 14693528
Drug: GW433908 1,860
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GW433908 1,860 mg BID
Trial: 14693528
Drug: Amprenavir 1,200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amprenavir 1,200 mg BID
Trial: 9835204
Drug: Collagenase treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Collagenase treatment of aorta
Trial: 2553325
Drug: Atrial natriuretic
RxNorm normalized name: Atrial natriuretic factor
DrugBank: Atrial natriuretic peptide (DB15591)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atrial natriuretic factor infusion
Trial: 15358983
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg L-dopa
Trial: 2824706
Drug: Cisplatin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin (200 mg/m2 divided in five daily doses) and vinblastine (7.5 mg/m2 as a continuous IV infusion over five days) followed by radiation therapy
Trial: 2824706
Drug: Cisplatin and
RxNorm normalized name: A micelle drug formulation composed of cisplatin and mPEG-poly(l-Glu) diblock copolymer with 1,3-propanediyl linkagecisplatin is incorporated in polymeric micelles via polymer-metal complex formation with cis-geometry of PT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin and vinblastine followed by radiation therapy
Trial: 2824706
Drug: Cisplatin and
RxNorm normalized name: A micelle drug formulation composed of cisplatin and mPEG-poly(l-Glu) diblock copolymer with 1,3-propanediyl linkagecisplatin is incorporated in polymeric micelles via polymer-metal complex formation with cis-geometry of PT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin and vinblastine followed by radiation therapy for nonresponders
Trial: 30990213
Drug: Bread fortified
RxNorm normalized name: Eazi-Breed CIDR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bread fortified with 2.3 g PS and 228 mg CC (PS-C)
Trial: 30990213
Drug: Bread fortified
RxNorm normalized name: Eazi-Breed CIDR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bread fortified with placebo (PL) and curcumin (CC) (PL-C)
Trial: 26867333
Drug: Fennel tea
RxNorm normalized name: Fennel
DrugBank: Fennel (DB15615)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fennel tea (5 grams of dried fennel fruit in 130 mL boiled water, twice per day)
Trial: 26867333
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (equal quantity of water, twice per day)
Trial: 21710343
Drug: High-dose N-acetylcysteine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose N-acetylcysteine (N-ACC) 2 × 1200 mg/d for 48 h with optimal hydration
Trial: 16524858
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no LT4 therapy)
Trial: 15631797
Drug: Cefdinir 100
RxNorm normalized name: Cefdinir
DrugBank: Cefdinir (DB00535)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefdinir 100 mg, orally, three times a day for 7-14 days
Trial: 15631797
Drug: Cefaclor 500
RxNorm normalized name: cefaclor 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefaclor 500 mg, orally, three times a day for 7-14 days
Trial: 9379067
Drug: Patient-controlled analgesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient-controlled analgesia (PCA) with background opioid infusion
Trial: 2863392
Drug: 10 mg.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg. dezocine
Trial: 2863392
Drug: 15 mg.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg. dezocine
Trial: 2863392
Drug: 10 mg.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg. morphine
Trial: 2863392
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (dezocine and morphine)
Trial: 29176383
Drug: Jump Interval
RxNorm normalized name: Minerval
DrugBank: Idroxioleic acid (DB18213)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Jump Interval Training (JIT) - performed twice per week, consisting of 4-6 bouts of continuous vertical jumping (30 seconds) with 5-minute intervals
Trial: 24485479
Drug: Clonidine (0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine (0.15 mg orally)
Trial: 22961867
Drug: Acute oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acute oral antioxidant cocktail (AOC) consisting of vitamin C, E, and α-lipoic acid
Trial: 20591671
Drug: ST/G reconstruction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ST/G reconstruction
Trial: 18093299
Drug: Cryokinetic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cryokinetic treatment (intermittent ice applications with compression and therapeutic exercise)
Trial: 11155139
Drug: Systemic interferon‐alpha‐2A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic interferon‐alpha‐2A treatment
Trial: 29111889
Drug: Dietary supplement
RxNorm normalized name: dietary supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary supplement containing raspberry ketone, capsaicin, caffeine, garlic, and Citrus aurantium (EXP)
Trial: 29111889
Drug: Dietary supplement
RxNorm normalized name: dietary supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary supplement (EXP)
Trial: 24694358
Drug: Vicco(®) turmeric
RxNorm normalized name: Turmeric
DrugBank: Turmeric (DB14276)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vicco(®) turmeric cream (VTC) applied five times a day
Trial: 20706632
Drug: Peptide vaccine
RxNorm normalized name: E39 peptide vaccine
DrugBank: GALE-301 (DB17262)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peptide vaccine (1 or 4 mg)
Trial: 17510493
Drug: L-lysine (2.64
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-lysine (2.64 g per day) and L-arginine (2.64 g per day)
Trial: 29726939
Drug: Ustekinumab 90
RxNorm normalized name: ustekinumab 90 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ustekinumab 90 mg every 12 weeks (q12w)
Trial: 29726939
Drug: Ustekinumab 90
RxNorm normalized name: ustekinumab 90 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ustekinumab 90 mg every 8 weeks (q8w)
Trial: 30375189
Drug: Adenosine-loaded DMN
RxNorm normalized name: Adenosine
DrugBank: Adenosine phosphate (DB00131)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adenosine-loaded DMN (Ad-DMN) patches and topical adenosine-loaded cream (Ad-cream)
Trial: 30375189
Drug: Topical adenosine-loaded
RxNorm normalized name: Adenosine
DrugBank: Adenosine phosphate (DB00131)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical adenosine-loaded cream (Ad-cream)
Trial: 21234793
Drug: Intervention group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention group (n=30) participated in three weekly group sessions followed by three weekly follow-up telephone calls over six weeks.
Trial: 18300284
Drug: Phenserine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenserine (30 mg/day)
Trial: 10391179
Drug: P‐IGIV 1500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: P‐IGIV 1500 mg/kg
Trial: 10391179
Drug: P‐IGIV 750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: P‐IGIV 750 mg/kg
Trial: 10391179
Drug: P‐IGIV 250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: P‐IGIV 250 mg/kg
Trial: 9627768
Drug: Felodipine ER
RxNorm normalized name: Felodipine ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine ER (2.5 mg)
Trial: 18831357
Drug: Ramipril (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramipril (2.5 mg)
Trial: 9010611
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (Felodipine ER 2.5 mg / Ramipril 2.5 mg)
Trial: 9052345
Drug: Felodipine ER
RxNorm normalized name: Felodipine ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine ER monotherapy
Trial: 2005326
Drug: Local immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local immunotherapy (LIT) with Dermatophagoides extract
Trial: 319424
Drug: Indomethacin (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (150 mg daily)
Trial: 23152865
Drug: Real acupuncture
RxNorm normalized name: REAL FOODS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Real acupuncture (RA) and treatment instruction (TI)
Trial: 23152865
Drug: Real acupuncture
RxNorm normalized name: REAL FOODS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Real acupuncture (RA) and non-treatment instruction (NI)
Trial: 23152865
Drug: Sham acupuncture
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham acupuncture (SA) and treatment instruction (TI)
Trial: 23152865
Drug: Sham acupuncture
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham acupuncture (SA) and non-treatment instruction (NI)
Trial: 1928019
Drug: Relapse Prevention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Relapse Prevention Therapy (RPT)
Trial: 15983299
Drug: Pioglitazone 30
RxNorm normalized name: pioglitazone 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pioglitazone 30 mg once daily for 12 weeks followed by 45 mg once daily for an additional 12 weeks
Trial: 15983299
Drug: Rosiglitazone 4
RxNorm normalized name: rosiglitazone 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosiglitazone 4 mg once daily followed by 4 mg twice daily for the same intervals
Trial: 12464326
Drug: Haloperidol (dopamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol (dopamine D2-receptor antagonist)
Trial: 10603715
Drug: CIC antibody
RxNorm normalized name: digoxin antibodies Fab fragments Injection [DigiFab]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CIC antibody levels during leprosy reactions
Trial: 7860911
Drug: Sotalol (320
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sotalol (320 mg twice daily)
Trial: 1781047
Drug: RT (no
RxNorm normalized name: PIGGYBACK WITH VIAL PORT (NON-THREADED)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RT (no further therapy)
Trial: 6109587
Drug: 5-mg oral
RxNorm normalized name: Augmentin 875-mg Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-mg oral doses of prazosin
Trial: 30649458
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg of tapentadol
Trial: 30649458
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg of tramadol
Trial: 30649458
Drug: Inert placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inert placebo (calcium tablets)
Trial: 30463785
Drug: Rectal washout
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal washout with povidone‐iodine (RW‐PI)
Trial: 30463785
Drug: Rectal washout
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal washout with Ringer solution with an irrigation instrument (RW‐R)
Trial: 30463785
Drug: Rectal washout
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal washout with Ringer solution without an irrigation instrument (RW)
Trial: 16569820
Drug: Maribavir 400
RxNorm normalized name: MARIBAVIR
DrugBank: Maribavir (DB06234)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Maribavir 400 mg twice daily for 10 days
Trial: 12972305
Drug: Normal haemoglobin
RxNorm normalized name: Abnormal haemoglobin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal haemoglobin group (>/=13 g/dl in males, >/=12 g/dl in females)
Trial: 12972305
Drug: Anaemic group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anaemic group (<13 g/dl in males, <12 g/dl in females)
Trial: 10548200
Drug: Dopexamine infusion
RxNorm normalized name: dopexamine
DrugBank: Dopexamine (DB12313)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopexamine infusion (0.5, 1.0, 2.0, and 4.0 microg/kg/min)
Trial: 7936339
Drug: Dopexamine infusion
RxNorm normalized name: dopexamine
DrugBank: Dopexamine (DB12313)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopexamine infusion
Trial: 8740612
Drug: Epidural lignocaine
RxNorm normalized name: lidocaine hydrochloride Injectable Solution [Sure-Amp Lignocaine hydrochloride]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural lignocaine (40 mg)
Trial: 8740612
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of clonidine (150 micrograms) and lignocaine (40 mg)
Trial: 8740612
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of clonidine and lignocaine
Trial: 25693652
Drug: All injections
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All injections
Trial: 30790690
Drug: Control (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (oral P2Y12 inhibitors)
Trial: 12919177
Drug: Complementary medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Complementary medicine
Trial: 11080723
Drug: 5 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 g of MSG
Trial: 11080723
Drug: Increasing doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increasing doses of MSG
Trial: 11080723
Drug: 5 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 g of MSG with food
Trial: 8445420
Drug: Tamoxifen (Tam)
DrugBank: Tamoxifen (DB00675)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tamoxifen (Tam) 30 mg/d for 2 years
Trial: 3885700
Drug: Propafenone, 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propafenone, 300 mg every 8 hours
Trial: 3885700
Drug: Disopyramide, 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disopyramide, 200 mg every 8 hours
Trial: 26905433
Drug: Dialysate calcium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dialysate calcium at 1.25 mmol/l
Trial: 26905433
Drug: Dialysate calcium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dialysate calcium at 1.5 mmol/l (Control)
Trial: 22235139
Drug: Brivaracetam 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brivaracetam 200 mg single oral dose
Trial: 21039672
Drug: Velusetrag 15
RxNorm normalized name: Velusetrag
DrugBank: Velusetrag (DB12702)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Velusetrag 15 mg
Trial: 21039672
Drug: Velusetrag 30
RxNorm normalized name: Velusetrag
DrugBank: Velusetrag (DB12702)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Velusetrag 30 mg
Trial: 21039672
Drug: Velusetrag 50
RxNorm normalized name: Velusetrag
DrugBank: Velusetrag (DB12702)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Velusetrag 50 mg
Trial: 10529044
Drug: metered-dose inhaler
RxNorm normalized name: Metered Dose Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: metered-dose inhaler and Volumatic
Trial: 25347936
Drug: Hyaluronidase group
RxNorm normalized name: Hyaluronidase
DrugBank: Hyaluronidase (DB14740)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Hyaluronidase group (ropivacaine 0.5% with 100 IU/ml of hyaluronidase)
Trial: 23777849
Drug: Capsaicin inhalation
RxNorm normalized name: Capsaicin
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Capsaicin inhalation (0.48‐1000 μmol/L, 4 inhalations per dose)
Trial: 23777849
Drug: Capsaicin inhalation
RxNorm normalized name: Capsaicin
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Capsaicin inhalation
Trial: 15297192
Drug: Cisplatin and
RxNorm normalized name: A micelle drug formulation composed of cisplatin and mPEG-poly(l-Glu) diblock copolymer with 1,3-propanediyl linkagecisplatin is incorporated in polymeric micelles via polymer-metal complex formation with cis-geometry of PT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin and irinotecan (25 mg/m² and 65 mg/m² weekly for three consecutive weeks, repeated every 28 days)
Trial: 3535022
Drug: Colloidal bismuth
RxNorm normalized name: Colloidal bismuth subcitrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colloidal bismuth subcitrate (CBS) administered twice daily
Trial: 3535022
Drug: Colloidal bismuth
RxNorm normalized name: Colloidal bismuth subcitrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colloidal bismuth subcitrate (CBS) administered four times daily
Trial: 31865665
Drug: Mobilization and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mobilization and SACS injection
Trial: 31865665
Drug: SACS injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SACS injection only
Trial: 19597646
Drug: Cefepime (CFP)
DrugBank: Cefepime (DB01413)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefepime (CFP) monotherapy
Trial: 17065275
Drug: Topical cord
RxNorm normalized name: Bos taurus umbilical cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical cord applications of mustard oil
Trial: 17065275
Drug: Topical applications
RxNorm normalized name: honey based topical applications
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical applications of other potentially unclean substances
Trial: 12512233
Drug: Losartan (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan (50 mg/daily per oral)
Trial: 2696483
Drug: Inadine (rayon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inadine (rayon dressing with 10 per cent povidone iodine ointment)
Trial: 19380660
Drug: Acitretin (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acitretin (25 mg) plus Pioglitazone hydrochloride (15 mg)
Trial: 19380660
Drug: Acitretin (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acitretin (25 mg) plus placebo
Trial: 11352437
Drug: Single 200mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single 200mg oral dose of moxifloxacin
Trial: 3296721
Drug: Diet treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet treatment and one of five active drug regimens (enalapril, doxazosin, acebutolol, amlodipine, chlorthalidone)
Trial: 3296721
Drug: Diet treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet treatment alone
Trial: 29335748
Drug: Hydrogel implant
RxNorm normalized name: Hydrogen
DrugBank: Hydrogen (DB15127)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrogel implant (Cartiva™)
Trial: 25004265
Drug: Norepinephrine (NE)
DrugBank: Norepinephrine (DB00368)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Norepinephrine (NE) infusion (0.15 mcg/kg/min)
Trial: 10228257
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline infusion (placebo)
Trial: 1461625
Drug: Megestrol acetate
RxNorm normalized name: Megestrol Acetate
DrugBank: Megestrol (DB19378)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Megestrol acetate at a dose of 480 mg/day for 3-4 months
Trial: 1461625
Drug: Megestrol acetate
RxNorm normalized name: Megestrol Acetate
DrugBank: Megestrol (DB19378)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Megestrol acetate at a dose of 160 mg/day for 3-4 months
Trial: 1461625
Drug: Megestrol acetate
RxNorm normalized name: Megestrol Acetate
DrugBank: Megestrol (DB19378)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Megestrol acetate (combined data for both doses)
Trial: 6428619
Drug: Insulin (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin (up to 48 units of highly purified porcine lente insulin)
Trial: 31697453
Drug: Oral health
RxNorm normalized name: CETYLPYRIDINIUM CHLORIDE 0.07 g in 100 mL ORAL RINSE [Assured Oral Health Fresh Mint]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral health program including individual oral hygiene monitoring for 2 months, awareness sessions, practical demonstration of toothbrushing and adaptive techniques with role-play.
Trial: 28190468
Drug: 1% w/w
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% w/w CA-oil lotion
Trial: 28190468
Drug: 5% w/w
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% w/w CA-oil lotion
Trial: 28190468
Drug: Placebo (base-lotion)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (base-lotion)
Trial: 29989857
Drug: Intensity‐modulated radiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensity‐modulated radiation therapy (IMRT)
Trial: 27259317
Drug: Conventional radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional radiation therapy (CRT)
Trial: 23880258
Drug: 2% chlorhexidine
RxNorm normalized name: CHLORHEXIDINE GLUCONATE 1.2 [iU] in 1 mL BUCCAL MOUTHWASH [0.12% Chlorhexidine Gluconate Oral Rinse]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% chlorhexidine (CHX) gel (G2)